Home > Insider Trading > Filing (0001214659-24-000495)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1677077	Alzamend Neuro Inc.	ALZN	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1212502	Iii C Milton Ault	11411 Southern Highlands Parkway Suite 240 Las Vegas NV 89141		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-01-05	5,000	$1.02	768,365	No	4	P	Indirect	By Ault Lending, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Ault Lending, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	166,865	Direct
Common Stock	996,197	Indirect	By Ault Life Sciences, Inc.
Common Stock	666,665	Indirect	By Ault Life Sciences Fund, LLC

Footnotes

Includes 26,032 shares of common stock previously owned by, and received from, Ault Alpha LP ("Ault Alpha"), in connection with the liquidation of Ault Alpha on December 28, 2023. Those 26,032 shares were previously reported as beneficially owned by Mr. Ault as Ault Alpha also reported as an indirect beneficial ownership under Mr. Ault, so no change in beneficial ownership of those shares occurred in connection with the liquidation.
Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.